Open the mobile version, with barcode scanning
Class II Terminated

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd.

Why: Failed Dissolution Specifications

Company
Zydus Pharmaceuticals (USA) Inc
Pennington, NJ, United States
Reported
Dec 23, 2020
Recall started
Dec 3, 2020
Ended
Dec 20, 2022
Where sold
Nationwide
Amount
22,848 cartons
Full product description
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77
Lots / codes affected
M900412 December 2020 M904772 February 2021 M915745 October 2021

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.